Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 14342

1.

Basal Cell Carcinoma, PART II: Contemporary Approaches to Diagnosis, Treatment, and Prevention.

Cameron MC, Lee E, Hibler B, Giordano CN, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM.

J Am Acad Dermatol. 2018 May 18. pii: S0190-9622(18)30776-X. doi: 10.1016/j.jaad.2018.02.083. [Epub ahead of print] Review.

PMID:
29782901
2.

Tumor-Derived Apoptotic Vesicles: With Death They Do Part.

Muhsin-Sharafaldine MR, McLellan AD.

Front Immunol. 2018 May 7;9:957. doi: 10.3389/fimmu.2018.00957. eCollection 2018. Review.

PMID:
29780392
3.

Are ovarian cancer stem cells the target for innovative immunotherapy?

Wang L, Xu T, Cui M.

Onco Targets Ther. 2018 May 8;11:2615-2626. doi: 10.2147/OTT.S155458. eCollection 2018. Review.

PMID:
29780254
4.

Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus.

Lambrecht M, Eekers DBP, Alapetite C, Burnet NG, Calugaru V, Coremans IEM, Fossati P, Høyer M, Langendijk JA, Romero AM, Paulsen F, Perpar A, Renard L, de Ruysscher D, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Roelofs E, Nyström PW, Troost EGC; work package 1 of the taskforce “European Particle Therapy Network” of ESTRO.

Radiother Oncol. 2018 May 17. pii: S0167-8140(18)30241-X. doi: 10.1016/j.radonc.2018.05.001. [Epub ahead of print] Review.

PMID:
29779919
5.

Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score.

Sanduleanu S, Woodruff HC, de Jong EEC, van Timmeren JE, Jochems A, Dubois L, Lambin P.

Radiother Oncol. 2018 May 18. pii: S0167-8140(18)30179-8. doi: 10.1016/j.radonc.2018.03.033. [Epub ahead of print] Review.

PMID:
29779918
6.

Cardiotoxicity associated with radiotherapy in breast cancer: A question-based review with current literatures.

Zhu Q, Kirova YM, Cao L, Arsene-Henry A, Chen J.

Cancer Treat Rev. 2018 May 2;68:9-15. doi: 10.1016/j.ctrv.2018.03.008. [Epub ahead of print] Review.

PMID:
29777800
7.

Gearing up T-cell immunotherapy in cervical cancer.

Chauhan SR, Bharadwaj M.

Curr Probl Cancer. 2018 Apr 22. pii: S0147-0272(17)30200-3. doi: 10.1016/j.currproblcancer.2018.04.001. [Epub ahead of print] Review.

PMID:
29776594
8.

Diagnosis and Management of Gynecomastia for Urologists.

Baumgarten L, Dabaja AA.

Curr Urol Rep. 2018 May 17;19(7):46. doi: 10.1007/s11934-018-0796-x. Review.

PMID:
29774423
9.

Tumoral cavitation in colorectal cancer patients with unresectable lung metastasis treated with bevacizumab and chemotherapy.

Peng Y, Chen Y, Zhang X, Yang Y, Cao D, Bi F, Li Z, Gou H.

J Cancer Res Clin Oncol. 2018 May 17. doi: 10.1007/s00432-018-2656-y. [Epub ahead of print] Review.

PMID:
29774414
10.

Natural products: a hope for glioblastoma patients.

Vengoji R, Macha MA, Batra SK, Shonka NA.

Oncotarget. 2018 Apr 24;9(31):22194-22219. doi: 10.18632/oncotarget.25175. eCollection 2018 Apr 24. Review.

11.

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.

Hirsch FR, Kerr KM, Bunn PA Jr, Kim ES, Obasaju C, Pérol M, Bonomi P, Bradley JD, Gandara D, Jett JR, Langer CJ, Natale RB, Novello S, Paz-Ares L, Ramalingam SS, Reck M, Reynolds CH, Smit EF, Socinski MA, Spigel DR, Stinchcombe TE, Vansteenkiste JF, Wakelee H, Thatcher N.

Clin Lung Cancer. 2018 Mar 21. pii: S1525-7304(18)30056-1. doi: 10.1016/j.cllc.2018.03.014. [Epub ahead of print] Review.

PMID:
29773328
12.

Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?

Kunc M, Biernat W, Senkus-Konefka E.

Cancer Treat Rev. 2018 May 14;67:78-87. doi: 10.1016/j.ctrv.2018.05.005. [Epub ahead of print] Review.

PMID:
29772460
13.

Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer.

Duchnowska R, Loibl S, Jassem J.

Cancer Treat Rev. 2018 May 9;67:71-77. doi: 10.1016/j.ctrv.2018.05.004. [Epub ahead of print] Review.

PMID:
29772459
14.

"Super-active surveillance": MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer.

Bloom JB, Gold SA, Hale GR, Rayn KN, Sabarwal VK, Bakhutashvili I, Valera V, Turkbey B, Pinto PA, Wood BJ.

Gland Surg. 2018 Apr;7(2):166-187. doi: 10.21037/gs.2018.03.06. Review.

15.

Recent advances in managing/understanding meningioma.

Shaikh N, Dixit K, Raizer J.

F1000Res. 2018 Apr 24;7. pii: F1000 Faculty Rev-490. doi: 10.12688/f1000research.13674.1. eCollection 2018. Review.

16.

Clinical utility of hyperbaric oxygen therapy in genitourinary medicine.

Gandhi J, Seyam O, Smith NL, Joshi G, Vatsia S, Khan SA.

Med Gas Res. 2018 Apr 18;8(1):29-33. doi: 10.4103/2045-9912.229601. eCollection 2018 Jan-Mar. Review.

17.

Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme.

Huang L, Boling W, Zhang JH.

Med Gas Res. 2018 Apr 18;8(1):24-28. doi: 10.4103/2045-9912.229600. eCollection 2018 Jan-Mar. Review.

18.

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC).

Chae YK, Arya A, Iams W, Cruz MR, Chandra S, Choi J, Giles F.

J Immunother Cancer. 2018 May 16;6(1):39. doi: 10.1186/s40425-018-0349-3. Review.

19.

The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.

van Leeuwen CM, Oei AL, Crezee J, Bel A, Franken NAP, Stalpers LJA, Kok HP.

Radiat Oncol. 2018 May 16;13(1):96. doi: 10.1186/s13014-018-1040-z. Review.

20.

MR imaging findings in some rare neurological complications of paediatric cancer.

Okabe T, Nozaki T, Aida N, Starkey J, Enokizono M, Niwa T, Handa A, Numaguchi Y, Kurihara Y.

Insights Imaging. 2018 May 15. doi: 10.1007/s13244-018-0628-z. [Epub ahead of print] Review.

PMID:
29766473

Supplemental Content

Loading ...
Support Center